Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Miller K; Wang M; Gralow J; Dickler M; Cobleigh M; Perez EA; Shenkier T; Cella D; Davidson NE; The New England Journal Of Medicine, 2007, vol. 357, issue 26, p 2666, ISSN 15334406. ISBN 15334406.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef